Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Malaysia

EU-Malaysia FTA Presents Hidden Opportunities Despite Negative Perceptions

May 2011 | Industry Trend Analysis

BMI View: Despite negative public perceptions, free trade agreement (FTA) talks with the EU will boost Malaysia's overall economy. Multinational pharmaceutical companies will also benefit. Key concerns include the rise in private healthcare expenses due to the patent period extension and lower government revenues from tax tariffs.

To read the full article, please choose one of the following options:

Subcribers please log in